While Glenmark Pharmaceuticals reported that the consolidated net profit declined by 46.70% to Rs 46.11 crore from the previous year’s Rs 86.52 crore, BHEL reported a net profit of Rs.1432 crore against Rs.1412 crore in the previous quarter, during the quarter ending December 30th, 2011. Shares of Glenmark closed at Rs 312.15 on BSE, down […]
Continue Reading...
